Moderna
Moderna will manufacture and deliver 100 million doses of its vaccine, mRNA-1273, while clinical trials are underway, according to a statement from the company. 100 million doses is part of a $1.525 billion deal struck with the federal government. Manufacturing the mRNA-1273 vaccine during clinical trial aims to expedite the traditional development timeline in accordance with the federal government’s Operation Warp Speed, a program that seeks to produce 300 million doses of a safe coronavirus preventative by January 2021.anonymous Investing August 12, 2020 at 9:58 am 0 0
Post a Comment
Search Thoughts
Biotech Categories
Recent Tags
biotech experts cdots nanoparticle pfizer vaccine pfizer biontech vaccine moderna leronlimab cytodyn covid-19 sinovac covid19 vaccine covid-19 coronavirus covid19 clinicaltrial coronavirus vaccine who coronavirus vaccine vaccine novavax covid19 dna vaccine rna biontech
Other sites:Executive Dating
Stupid Coworkers
Business Blog
Good News Network
Coupon Codes
Thought Tags
Get Social and Share